Kairos Pharma Ltd. has announced a change in its certifying accountants as part of its recent financial reporting update. On April 23, 2025, the company's audit committee appointed Weinberg and Company, P.A. as its new independent registered public accounting firm for the fiscal year ending December 31, 2025. This decision resulted in the dismissal of Marcum LLP, effective on the same date. Marcum's audit reports for the years ended December 31, 2024, and 2023 included no adverse opinions or disclaimers, although the 2023 report noted uncertainty regarding the company's ability to continue as a going concern. There were no disagreements or reportable events with Marcum regarding accounting principles or practices. This transition follows the identification of material weaknesses in internal controls over financial reporting for the fiscal years 2024 and 2023.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.